26%), although the difference did not reach statistical significance ( p = 0.144).
← all excerpts
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis.
1
0.1440
0.1440
26%), although the difference did not reach statistical significance ( p = 0.144).